These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31786269)

  • 21. Silver and fullerene nanoparticles' effect on interleukin-2-dependent proliferation of CD4 (+) T cells.
    Côté-Maurais G; Bernier J
    Toxicol In Vitro; 2014 Dec; 28(8):1474-81. PubMed ID: 25172299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pristine C
    Demir E; Nedzvetsky VS; Ağca CA; Kirici M
    Neurochem Res; 2020 Oct; 45(10):2385-2397. PubMed ID: 32712876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative effects of sulfhydryl compounds on target organellae, nuclei and mitochondria, of hydroxylated fullerene-induced cytotoxicity in isolated rat hepatocytes.
    Nakagawa Y; Inomata A; Ogata A; Nakae D
    J Appl Toxicol; 2015 Dec; 35(12):1465-72. PubMed ID: 25809591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective effect of reduced glutathione C60 derivative against hydrogen peroxide-induced apoptosis in HEK 293T cells.
    Huang J; Zhou C; He J; Hu Z; Guan WC; Liu SH
    J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):356-363. PubMed ID: 27376803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toxicity studies of fullerene C60 (1 μm and 50 nm) administered by nose-only inhalation to Wistar Han [Crl:WI (Han)] rats and B6C3F1/N mice.
    National Toxicology Program
    Toxic Rep Ser; 2020 Jul; (87):. PubMed ID: 33529180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxicity studies of fullerenes and derivatives.
    Kolosnjaj J; Szwarc H; Moussa F
    Adv Exp Med Biol; 2007; 620():168-80. PubMed ID: 18217343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C60 fullerene-pentoxifylline dyad nanoparticles enhance autophagy to avoid cytotoxic effects caused by the β-amyloid peptide.
    Lee CM; Huang ST; Huang SH; Lin HW; Tsai HP; Wu JY; Lin CM; Chen CT
    Nanomedicine; 2011 Feb; 7(1):107-14. PubMed ID: 20620236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C
    Hurmach Y; Rudyk M; Prylutska S; Hurmach V; Prylutskyy YI; Ritter U; Scharff P; Skivka L
    Mol Pharm; 2020 Sep; 17(9):3622-3632. PubMed ID: 32673486
    [No Abstract]   [Full Text] [Related]  

  • 29. Transferrin-mediated fullerenes nanoparticles as Fe(2+)-dependent drug vehicles for synergistic anti-tumor efficacy.
    Zhang H; Hou L; Jiao X; Ji Y; Zhu X; Zhang Z
    Biomaterials; 2015 Jan; 37():353-66. PubMed ID: 25453964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunotoxicity of nanoparticles: a computational study suggests that CNTs and C60 fullerenes might be recognized as pathogens by Toll-like receptors.
    Turabekova M; Rasulev B; Theodore M; Jackman J; Leszczynska D; Leszczynski J
    Nanoscale; 2014 Apr; 6(7):3488-95. PubMed ID: 24548972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biomedical potential of the reactive oxygen species generation and quenching by fullerenes (C60).
    Markovic Z; Trajkovic V
    Biomaterials; 2008 Sep; 29(26):3561-73. PubMed ID: 18534675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on the toxicity of an aqueous suspension of C60 nanoparticles using a bacterium (gen. Bacillus) and an aquatic plant (Lemna gibba) as in vitro model systems.
    Santos SM; Dinis AM; Rodrigues DM; Peixoto F; Videira RA; Jurado AS
    Aquat Toxicol; 2013 Oct; 142-143():347-54. PubMed ID: 24084257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biological evaluation and molecular dynamics simulation of water-soluble fullerene derivative C
    Gaponenko IN; Ageev SV; Iurev GO; Shemchuk OS; Meshcheriakov AA; Petrov AV; Solovtsova IL; Vasina LV; Tennikova TB; Murin IV; Semenov KN; Sharoyko VV
    Toxicol In Vitro; 2020 Feb; 62():104683. PubMed ID: 31639450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro toxicity assessment of three hydroxylated fullerenes in human skin cells.
    Saathoff JG; Inman AO; Xia XR; Riviere JE; Monteiro-Riviere NA
    Toxicol In Vitro; 2011 Dec; 25(8):2105-12. PubMed ID: 21964474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative toxicity of C60 aggregates toward mammalian cells: role of tetrahydrofuran (THF) decomposition.
    Kovochich M; Espinasse B; Auffan M; Hotze EM; Wessel L; Xia T; Nel AE; Wiesner MR
    Environ Sci Technol; 2009 Aug; 43(16):6378-84. PubMed ID: 19746740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic mitotoxicity of chloromethanes and fullerene C
    Seke M; Markelic M; Morina A; Jovic D; Korac A; Milicic D; Djordjevic A
    Protoplasma; 2017 Jul; 254(4):1607-1616. PubMed ID: 27913906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aqueous solubilization of C60 fullerene by natural protein surfactants, latherin and ranaspumin-2.
    Vance SJ; Desai V; Smith BO; Kennedy MW; Cooper A
    Biophys Chem; 2016; 214-215():27-32. PubMed ID: 27214760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct cytotoxic mechanisms of pristine versus hydroxylated fullerene.
    Isakovic A; Markovic Z; Todorovic-Markovic B; Nikolic N; Vranjes-Djuric S; Mirkovic M; Dramicanin M; Harhaji L; Raicevic N; Nikolic Z; Trajkovic V
    Toxicol Sci; 2006 May; 91(1):173-83. PubMed ID: 16476688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conjugation of dexamethasone to C60 for the design of an anti-inflammatory nanomedicine with reduced cellular apoptosis.
    Zhang Y; Wang L; Sun Y; Zhu Y; Zhong Z; Shi J; Fan C; Huang Q
    ACS Appl Mater Interfaces; 2013 Jun; 5(11):5291-7. PubMed ID: 23669026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The interactions of fullerene C
    Della Torre C; Maggioni D; Ghilardi A; Parolini M; Santo N; Landi C; Madaschi L; Magni S; Tasselli S; Ascagni M; Bini L; La Porta C; Del Giacco L; Binelli A
    Environ Pollut; 2018 Oct; 241():999-1008. PubMed ID: 30029334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.